Medtric Biotech
Lafayette
About Medtric Biotech
Medtric aims to provide a measurable difference by delivering clinically robust and economically sensible wound care solutions. They formed the company with this simple vision in mind. Focus on Innovation: Their company's focus is on developing innovative products to advance patient care. The company's flagship technology was developed collaboratively at leading research and medical institutions. Their nanoscale-based therapy was specifically engineered to protect wounds against infection and advance the healing process. Strategy for Growth: As they look to the future, their strategy is to enter the expanding clinical and over the counter wound care markets. It will also leverage this platform to penetrate alternative applications including the treatment of acne and other topical infections. Their strategy ensures a strong foundation with expansive capabilities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $279.6K
- Funding stage: Seed
- Last round: Pre-Seed (Mar 2013)
- Website: medtricbiotech.com
- Phone: 18328654955
Industries & Categories
Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/medtric-biotech-2885004 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.